The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if the linkage this equilibrium is closer to one it means every time you have apoe4 let's assume now we're talking about the long version of tom 40 you can have the long version of tone40 expressed with it now that linkage this equilibrium is what differs between ethnicities and can largely also explain why certain ethnicities develop disease and certain don't
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
how do we explain that not all apoe4 carriers have the same risk of alzheimer's disease and that's largely seen by ethnicity